Export

EN
FR
Ethambutol + isoniazid + pyrazinamide + rifampicin
Essential medicine status
General description
Ethambutol + isoniazid + pyrazinamide + rifampicin is a combination therapy primarily used to treat tuberculosis.
INN
Ethambutol + isoniazid + pyrazinamide + rifampicin
Medicine type
Chemical agent
Antibiotic groups
EML status history
First added in 1999 (TRS 895) for Tuberculosis
Therapeutic equivalent for
Recommendations
Section
Antituberculosis medicines
  • Oral > Solid: 275 mg + 75 mg + 400 mg + 150 mg tablet
Indications